These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3895924)

  • 1. Ceftazidime in the treatment of nosocomial sepsis.
    Young LS
    Am J Med; 1985 Aug; 79(2A):89-95. PubMed ID: 3895924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of ceftazidime in the treatment of nosocomial lower respiratory infections.
    Trenholme GM; Pottage JC; Karakusis PH
    Am J Med; 1985 Aug; 79(2A):32-6. PubMed ID: 3895916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftazidime-Avibactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination for the Treatment of Resistant Gram-negative Organisms.
    Sharma R; Park TE; Moy S
    Clin Ther; 2016 Mar; 38(3):431-44. PubMed ID: 26948862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with ceftazidime/avibactam for treatment of antibiotic-resistant organisms other than Klebsiella pneumoniae.
    Santevecchi BA; Smith TT; MacVane SH
    Int J Antimicrob Agents; 2018 Apr; 51(4):629-635. PubMed ID: 29408227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gram-negative pathogens in septicaemic infections.
    Young LS; Stevens P; Kaijser B
    Scand J Infect Dis Suppl; 1982; 31():78-94. PubMed ID: 6808659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of ceftriaxone versus ceftazidime in the treatment of nosocomial lower respiratory tract infections.
    Bassetti D; Cruciani M; Solbiati M; Rubini F; Gandola L; Valenti G; De Palma M; Corda R; Carimeo N
    Chemotherapy; 1991; 37(5):371-5. PubMed ID: 1804598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open study of ceftazidime in serious infections due to multiply-resistant bacteria.
    Pechère JC; Delisle R
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():181-8. PubMed ID: 6352619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of ceftazidime vs. carbenicillin and amikacin for treatment of neonatal septicemia.
    Odio CM; Umana MA; Saenz A; Salas JL; McCracken GH
    Pediatr Infect Dis J; 1987 Apr; 6(4):371-7. PubMed ID: 3295738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current guidelines for the treatment of severe pneumonia and sepsis.
    Bodmann KF
    Chemotherapy; 2005 Aug; 51(5):227-33. PubMed ID: 16103664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
    Scully BE; Neu HC
    Am J Med; 1985 Feb; 78(2):251-61. PubMed ID: 4038574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspects of clinical trials with ceftazidime worldwide.
    Foord RD
    Am J Med; 1985 Aug; 79(2A):110-3. PubMed ID: 3895913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and bacteriologic effectiveness of ceftazidime in infections with gram-positive pathogens].
    Tolxdorff-Neutzling R; Klages G; Danner H
    Infection; 1987; 15 Suppl 4():S195-9. PubMed ID: 3312034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.
    Wisplinghoff H; Bischoff T; Tallent SM; Seifert H; Wenzel RP; Edmond MB
    Clin Infect Dis; 2004 Aug; 39(3):309-17. PubMed ID: 15306996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Richards DM; Brogden RN
    Drugs; 1985 Feb; 29(2):105-61. PubMed ID: 3884319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
    Zhanel GG; Lam A; Schweizer F; Thomson K; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Noreddin AM; Karlowsky JA
    Am J Clin Dermatol; 2008; 9(4):245-54. PubMed ID: 18572975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftazidime versus tobramycin/ticarcillin in treating hospital acquired pneumonia and bacteremia.
    Rapp RP; Young B; Foster TS; Tibbs PA; O'Neal W
    Pharmacotherapy; 1984; 4(4):211-5. PubMed ID: 6384945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous ciprofloxacin or ceftazidime in selected infections. A prospective, randomized, controlled study.
    Villavicencio J; Asensio de Fernandez ME; Ramirez CA
    Am J Med; 1989 Nov; 87(5A):191S-194S. PubMed ID: 2686422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous ciprofloxacin and ceftazidime in serious infections. A prospective, controlled clinical trial with third-party blinding.
    Sifuentes-Osornio J; Macías A; Amieva RI; Ramos A; Ruiz-Palacios GM
    Am J Med; 1989 Nov; 87(5A):202S-205S. PubMed ID: 2686425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empiric antimicrobial therapy with aztreonam or ceftazidime in gram-negative septicemia.
    Lagast H; Klastersky J; Kains JP; van der Auwera P; Meunier F; Woussen F; Thijs JP
    Am J Med; 1986 May; 80(5C):79-84. PubMed ID: 3521272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.